9–10 June 2022
Beactica Therapeutics participates in Discovery Europe in Berlin, Germany.
Join our Head of Operations Johan Winquist and over 400 other industry leaders at this event which will address the latest advancements in target identification, validation and HIT optimisation.
Johan will be attending to network and talk with existing and future collaborators about the strength of our partner-validated drug discovery platform, as well as share our mission to develop novel therapeutics against genetically defined cancers, with high unmet medical need.
Are you attending? Get in touch with Johan to learn more about Beactica Therapeutics.
Sign up for the Beactica newsletter to receive our latest news and updates